Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis.

@article{Caete2004AntiangiogenicEO,
  title={Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis.},
  author={Juan D. Ca{\~n}ete and Jos{\'e} Luis Pablos and Raimon Sanmart{\'i} and Carmen Mallofr{\'e} and Sara Marsal and Joan Maym{\'o} and Jordi Gratac{\'o}s and Jovita Mezquita and Crist{\'o}bal Mezquita and Maria C Cid},
  journal={Arthritis and rheumatism},
  year={2004},
  volume={50 5},
  pages={1636-41}
}
OBJECTIVE Neovascularization, with an increased number of synovial vessels with a characteristic morphology, seems to contribute to the progression of psoriatic arthritis (PsA). Accordingly, angiogenesis may be an important therapeutic target in PsA. The aim of this study was to analyze the effects of infliximab on angiogenesis in the synovial membrane of patients with PsA who responded to this therapy. METHODS The study group comprised 9 patients with PsA who were selected for the presence… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 47 extracted citations

Angiogenesis drives psoriasis pathogenesis.

International journal of experimental pathology • 2009
View 4 Excerpts
Highly Influenced

Treatments for psoriatic arthritis

View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…